Search
Bio-Techne Corp
TECHAdd to Watchlist
72.800USD
-0.020-0.03%
Close 11-11 16:00（ET）
11.43BMarket Cap
103.15P/E TTM
After-hours 16:04 (ET)72.850USD+0.060+0.08%
After-hours 16:04 (ET)Bio-Techne Corp (TECH) Stock Price Target & Forecast
Analyst Rating
Based on 14 analysts giving stock ratings to Bio-Techne Corp in the past month.
Hold
1 Strong Buy
0 Buy
13 Hold
0 Sell
0 Strong Sell
Target Price
70.019USD-3.63%
TECH Analyst Recommendation Trends
In the current month, TECH has received 0 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. TECH average Analyst price target in the last month is 70.019.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
1
1
1
1
5
5
5
5
0
0
3
4
6
7
7
7
13
14
12
12
4
5
5
5
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
14
15
16
17
16
17
17
17
TECH Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, TECH EPS is projected to reach 0.482 in FY2027Q2, following reported EPS of 0.180 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
Forecast
0.54
0.52
0.44
0.48
0.56
Actual
0.33
0.35
0.18
--
--
Surprise
-39.27%
-32.60%
-59.00%
--
--
FAQs
What is Bio-Techne Corp's expected revenue for the next quarter?
Bio-Techne Corp's expected revenue is 307.79M.
What is Bio-Techne Corp's price target?
Analysts forecast that Bio-Techne Corp's price target is USD 70.02, with the highest forecast at USD 75.00 and the lowest forecast at USD 50.00.
How have Bio-Techne CorpTECH's recent earnings per share performed?
The market expectation was USD 0.18, while Bio-Techne CorpTECH's earnings per share (EPS) for the previous quarter was USD 0.35. EPS for the next quarter is expected at USD 0.48.
What is the analyst rating for Bio-Techne Corp?
Based on the ratings of Bio-Techne Corp's stock from 14 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.